Sr. Medical Director/Executive Director, Early Clinical Development

3+ (Senior) / 6+ (Executive) years’ industry/ academic clinical development experience in hematology/oncology, leading cross-functional development teams is required.

Sub-specialization and/or clinical development experience in cell therapies or CAR-T is highly desirable.

Demonstrated excellence and experience in first-in-human clinical development including the design, execution of first in human trial, and submission of INDs.

Able to anticipate biometrics, regulatory, clinical operations, development sciences, pharmacovigilance, and other development needs to ensure successful program delivery

Ability to communicate effectively with cross functional teams such as pre-clinical scientists, clinical operations, safety-PV, biomarker, biostatistics, regulatory, and project management including peer to peer interactions with academic scientific experts, KOLs and stake holders.

Ensures compliance with corporate policies and procedures, as well as, all related healthcare laws and regulations

Sr. Medical Director, Early Clinical Development- $294,483 - $386,511

Executive Medical Director, Early Clinical Development- $338,656- $444,486

#Li-AS1

#Li-Hybrid

The base pay range below is what Legend Biotech USA Inc. reasonably expects to offer at the time of posting. Actual compensation may vary based on experience, skills, qualifications, and geographic location. The company reserves the right to modify this range as needed and in accordance with applicable laws.

Other Types of Pay: Performance-based bonus and/or equity is available to employees in eligible roles.

Medical Director/Executive Director of Early Clinical Development is a critical role in the company with significant impact on the development and life cycle of drug development projects

The candidate for this role will be responsible to lead the Early Clinical Development Team, for IND submission and the design, execution and oversight of first-in-human, dose finding clinical trials.

Full understanding of tenets of FIH studies (e.g.

dose selection rationale, biomarker plans, etc.) and the relevant compliance framework for clinical development activities are essential.

Lead clinical science aspects of design, execution, interpretation and reporting of early (first in human) stage clinical trials.

Collaborate with scientists and technical experts to integrate cellular therapy specific aspects of PK/PD, diagnostic, and biomarker plans into the overall clinical development strategy.

For information related to our privacy notice, please review:

Legend Biotech Privacy Notice

.